Bioimpedance Analyzers Market Share & Growth | Forecast 2031

Bioimpedance Analyzers Market Share & Growth | Forecast 2031

Segments - Bioimpedance Analyzers Market by Products (Single-frequency Analyzers, Dual-frequency Analyzers, Multi-frequency Analyzers, Whole Body Bioimpedance Measurement, Bioimpedance Spectroscopy, Body Segment Bioimpedance Measurement, and Alternative Bioimpedance Analysis Method), Modality (Wireless Bioimpedance Analyzers and Wired Bioimpedance Analyzers), Applications (Segmental Body Measurement and Whole-body Measurement), End-users (Home Users, Fitness Clubs and Wellness Centers, Hospitals, and Other), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/Raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Shruti
Editor : Shruti Bhat

Upcoming | Report ID :ICT-SE-3941 | 4.8 Rating | 67 Reviews | 175 Pages | Format : PDF Excel PPT

Report Description


The Global Bioimpedance Analyzers Market size was USD 472.76 Million in 2022 and is anticipated to reach USD 1133.12 Million by 2031, expanding at a CAGR of 10.2% during forecast period, 2023 to 2031Rising awareness of healthy lifestyles, increasing prevalence of lifestyle diseases including obesity, and rising number of fitness clubs across the globe are primary factors driving the bioimpedance analyzers market.

Bioimpedance analyzers (BIA) are a type of screening device that can be used to accurately measure and assess body composition and fat. It is a non-invasive technology used by medical professionals to determine body fat percentage. It enables the calculation of muscle tissue percentages, hydration percentages, metabolic rate, bone weight, and fitness levels. A variety of ways for interpreting measured bioimpedance data, and a wide range of bioimpedance applications in body composition calculation.

Bioimpedance Analyzers Market Outlook

Bioimpedance analyzers work on the electrical conductivity principle. Bioimpedance analyzers are gaining popularity as a result of their ease of use and the wide variety of parameters it can monitor. Two electrodes are placed on a person's right hand and foot during the test. The body transmits a low-level, undetectable electrical current. The amount of water in a patient's body affects the flow of current through the body. The instrument monitors how the signal is impeded as it passes through different types of tissue. Blood, for example, has a high conductivity as it contains a big amount of fluid and electrolytes. The signal is slowed by fat and bone. Bioimpedance analyzers are used to assess the resistance to current flow as it goes through the body, they can provide estimations of body water, which can then be used to compute body fat using particular instruments.

The COVID-19 pandemic is expected to have a favorable impact on the market for bioimpedance analyzers. Furthermore, people's lives have become stressful as a result of lockdowns and stay-at-home orders. People have more free time than they had previously. Consumers are drinking carbo-hydrated drinks and consuming unhealthy fat due to changes in lifestyle and increased convenience of home-delivered food. Many people are resorting to home exercise regimens and fitness courses as their health awareness grows. These improvements are likely to have an impact on the demand for bioimpedance analyzers for health monitoring.

  • Increase in digitization in the healthcare industry and rise in healthcare spending across the globe are expected to boost the market in the coming years.

  • Growing prevalence of lifestyle diseases such as high blood pressure, obesity, and diabetes is anticipated to drive the market during the forecast period.

  • Prevalence of obesity worldwide increased from 30.5% in 2000 to 42.4% in 2019, according to the Centers for Disease Control and Prevention (CDC). Obesity has been dubbed a global issue, with estimates predicting that 57.8% of all individuals would be obese by 2030. It is increasingly a problem in low- and middle-income countries. Bioimpedance analyzers are used to determine the amount of fat, muscle, and bone in a person's body; therefore, rising prevelance of obesity is expected to boost the bioimpedance analyzers market during the forecast period.

  • Rising number of fitness clubs, sports rehabilitation center, and weight loss clinics is anticipated to drive the market in the coming years.

  • Variability in the accuracy of many bioimpedance analyzers is expected to hinder the market during the forecast period. Despite technological improvements, getting appropriate body fat measurements from the most commercially available body fat analyzers is difficult. Analyzers function by transmitting an electrical current through the body that follows the route of least resistance. The fat-free mass has the lowest impedance to electrical current, as fat contains less water. These analyzers are unable to detect a significant quantity of fat beneath the skin. Furthermore, body immunity differs between ethnic groups, thus affecting the accuracy of body composition analyzers.

  • The bioimpedance analyzers market is projected to grow rapidly in emerging economies such as India, China, and Brazil due to an increase in the prevalence of lifestyle diseases, rising awareness regarding health and obesity, and improvements in infrastructure in these nations. Recent infrastructure upgrades, strong economic expansion, surging demand, and public-private partnerships to fund healthcare research, are expected to fuel the market in China.

Scope of Bioimpedance Analyzers Market Report

The report on the global bioimpedance analyzers market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes                                      

Details

Report Title

Bioimpedance Analyzers Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Single-frequency Analyzers, Dual-frequency Analyzers, Multi-frequency Analyzers, Whole Body Bioimpedance Measurement, Bioimpedance Spectroscopy, Body Segment Bioimpedance Measurement, and Alternative Bioimpedance Analysis Method), Modality (Wireless Bioimpedance Analyzers and Wired Bioimpedance Analyzers), Applications (Segmental Body Measurement and Whole-body Measurement), End-users (Home Users, Fitness Clubs and Wellness Centers, Hospitals, and Other)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

OMRON Healthcare, Inc., Tanita., InBody Pvt. Ltd., RJL Systems, Inc., EVOLT 360, Charder Electronic Co, Ltd., Fook Tin Technologies Ltd., BioTekna, Withings, Biodynamics Corporatio, SMT Medical Technology GmbH,Xiaomi., Sino-Hero(Shenzhen)Bio-Medical Electronics Co.,Ltd., LUMSAIL MEDICAL & AESTHETICS INDUSTRIAL INC., and Bioparhom

 

Global Bioimpedance Analyzers MarketSegment Insights

Based on products, the market is divided into single-frequency analyzers, dual-frequency analyzers, multi-frequency analyzers, whole-body bioimpedance measurement, bioimpedance spectroscopy, body segment bioimpedance measurement, and alternative bioimpedance analysis method. The multi-frequency analyzers segment is expected to account for a key share of the market during the forecast period. End-users prefer multi-frequency bioimpedance analyzers over single-frequency bioimpedance analyzers, as they can be used for segmental and whole-body measurements, unlike single-frequency bioimpedance analyzers.

In terms of modality, the bioimpedance analyzers market is bifurcated into wireless bioimpedance analyzers and wired bioimpedance analyzers. The wireless bioimpedance analyzers segment is projected to account for a considerable share of the market. Advancements in wireless technologies and increase in the demand for wireless bioimpedance analyzers are expected to boost the segment.

Bioimpedance Analyzers Market Modality

Based on applications, the market is segregated into segmental body measurement and whole-body measurement. The segmental body measurement segment is anticipated to account for a significant share of the market during the forecast period owing to the increasing prevalence of metabolic disorders and obesity.

In terms of end-users, the bioimpedance analyzers market is segregated into home users, fitness clubs and wellness centers, hospitals, and others. The fitness clubs and wellness centers segment is projected to account for a considerable share of the market during the forecast period. Rising awareness about health and fitness around the world, and rising number of fitness clubs and wellness facilities are driving the segment.

Bioimpedance Analyzers Market End Users

On the basis of regions, the global bioimpedance analyzers market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held the key share of the global bioimpedance analyzers market owing to increasing obesity rate, government attempts to encourage healthy lifestyles, rising use of body composition analyzers to test athlete fitness, and increasing number of health clubs and fitness centers.

Bioimpedance Analyzers Market Regions

Segments

By Products

  • Single-frequency Analyzers
  • Dual-frequency Analyzers
  • Multi-frequency Analyzers
  • Whole Body Bioimpedance Measurement
  • Bioimpedance Spectroscopy
  • Body Segment Bioimpedance Measurement
  • Alternative Bioimpedance Analysis Method

By Modality

  • Wireless Bioimpedance Analyzers
  • Wired Bioimpedance Analyzers

By Applications

  • Segmental Body Measurement
  • Whole-body Measurement

By End-users

  • Home Users
  • Fitness Clubs and Wellness Centers
  • Hospitals
  • Other

By Regions

  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East & Africa

By Key Players

  • OMRON Healthcare, Inc.
  • Tanita
  • InBody Pvt. Ltd.
  • RJL Systems, Inc.
  • EVOLT 360
  • Charder Electronic Co, Ltd.
  • Fook Tin Technologies Ltd.
  • BioTekna
  • Withings
  • Biodynamics Corporatio
  • SMT Medical Technology GmbH
  • Xiaomi
  • Sino-Hero(Shenzhen)Bio-Medical Electronics Co.,Ltd.
  • LUMSAIL MEDICAL & AESTHETICS INDUSTRIAL INC.
  • Bioparhom

Competitive Landscape

Major players in the bioimpedance analyzers market are OMRON Healthcare, Inc., Tanita., InBody Pvt. Ltd., RJL Systems, Inc., EVOLT 360, Charder Electronic Co, Ltd., Fook Tin Technologies Ltd., BioTekna, Withings, Biodynamics Corporatio, SMT Medical Technology GmbH,Xiaomi., Sino-Hero(Shenzhen)Bio-Medical Electronics Co.,Ltd., LUMSAIL MEDICAL & AESTHETICS INDUSTRIAL INC., and Bioparhom.

Bioimpedance Analyzers Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioimpedance Analyzers Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Bioimpedance Analyzers Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Bioimpedance Analyzers Market - Supply Chain
  4.5. Global Bioimpedance Analyzers Market Forecast
     4.5.1. Bioimpedance Analyzers Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Bioimpedance Analyzers Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Bioimpedance Analyzers Market Absolute $ Opportunity
5. Global Bioimpedance Analyzers Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Bioimpedance Analyzers Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Bioimpedance Analyzers Demand Share Forecast, 2019-2026
6. North America Bioimpedance Analyzers Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Bioimpedance Analyzers Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Bioimpedance Analyzers Demand Share Forecast, 2019-2026
7. Latin America Bioimpedance Analyzers Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Bioimpedance Analyzers Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Bioimpedance Analyzers Demand Share Forecast, 2019-2026
8. Europe Bioimpedance Analyzers Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Bioimpedance Analyzers Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Bioimpedance Analyzers Demand Share Forecast, 2019-2026
9. Asia Pacific Bioimpedance Analyzers Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Bioimpedance Analyzers Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Bioimpedance Analyzers Demand Share Forecast, 2019-2026
10. Middle East & Africa Bioimpedance Analyzers Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Bioimpedance Analyzers Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Bioimpedance Analyzers Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Bioimpedance Analyzers Market: Market Share Analysis
  11.2. Bioimpedance Analyzers Distributors and Customers
  11.3. Bioimpedance Analyzers Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. OMRON Healthcare, Inc.
     11.4.2. Tanita
     11.4.3. InBody Pvt. Ltd.
     11.4.4. RJL Systems, Inc.
     11.4.5. EVOLT 360
     11.4.6. Charder Electronic Co, Ltd.
     11.4.7. Fook Tin Technologies Ltd.
     11.4.8. BioT

Methodology

Our Clients

Deloitte
Pfizer
Nestle SA
sinopec
The John Holland Group
Honda Motor Co. Ltd.
General Mills
General Electric